Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patients-Reference-Cited by-同舟云学术

Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patients

Published:2021-11-07 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Cariti C.¹^ORCID,Dapavo P.¹,Mastorino L.¹,Ortoncelli M.¹,Siliquini N.¹^ORCID,Merli M.¹,Avallone G.¹,Giordano S.¹,Fabrizio R.¹,Susca S.¹,Verrone A.¹,Stroppiana E.¹,Quaglino P.¹^ORCID,Ribero S.¹^ORCID

Affiliation:

1. Department of Medical Sciences Section of Dermatology University of Turin C.so Dogliotti Turin 14 – 10126 Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17766

Reference8 articles.

1. Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response

2. Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

3. Initial results of ixekizumab efficacy and safety in real‐world plaque psoriasis patients: a multicentre retrospective study

4. Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab

5. Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience;Journal of Personalized Medicine;2024-07-03

2. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials;Clinical, Cosmetic and Investigational Dermatology;2024-04

3. Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγt;RSC Advances;2024

4. Long-term efficacy, safety, and drug survival of secukinumab in patients with psoriasis in Turkey: a retrospective analysis of real-world experience;Advances in Dermatology and Allergology;2024

5. Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years;Journal of the European Academy of Dermatology and Venereology;2023-12-26